Evolent Health, Inc. (EVH) income statement
EVHNYSEServices-Management ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$3.93−0.69 (-14.94%)
Close on Nov 18, 2026Market cap $444.32MP/E –Yield –
Evolent Health, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 17.2%
- Operating margin
- -20.4%
- Net margin
- -24.1%
- Return on equity, FY2025
- -75.5%
Financial strength
- Current ratio
- 1.24
- Debt to equity
- 2.52
- Debt to assets
- 49.0%
- Cash to current liabilities
- 23.5%
Valuation
- P/E ratio
- –
- Price to sales
- 0.21
- Price to book
- 1.16
- Dividend yield
- –
See a number that looks wrong?